These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 8508990)

  • 21. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
    Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
    J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The effect of estradiol on human endometrial cancer. Experimental in vivo and in vitro studies].
    Horvath G
    Lakartidningen; 2000 May; 97(22):2746-50. PubMed ID: 10900896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Obesity and risk of cancer in the woman].
    Schindler AE
    Zentralbl Gynakol; 1998; 120(5):235-40. PubMed ID: 9629630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hormonal problems in diseases of the breast].
    Strnad P; Vachousek J; Cech E; Smejkal V; Velek J
    Ceska Gynekol; 1995 Jun; 60(3):164-6. PubMed ID: 7670712
    [No Abstract]   [Full Text] [Related]  

  • 25. The bioidentical hormone debate: are bioidentical hormones (estradiol, estriol, and progesterone) safer or more efficacious than commonly used synthetic versions in hormone replacement therapy?
    Holtorf K
    Postgrad Med; 2009 Jan; 121(1):73-85. PubMed ID: 19179815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Do female sex hormones initiate breast cancer? A review of the evidence.
    Wren BG
    Climacteric; 2004 Jun; 7(2):120-8. PubMed ID: 15497900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Postmenopausal hormone replacement under scrutiny. "Fatal therapy"?].
    Braendle W; Semler J
    MMW Fortschr Med; 2000 Aug; 142(33-34):11-2. PubMed ID: 10998894
    [No Abstract]   [Full Text] [Related]  

  • 28. Behavior of estrogen-associated female genital tract cancer and its relation to neoplasia following intrauterine exposure to diethylstilbestrol (DES).
    Herbst AL
    Gynecol Oncol; 2000 Feb; 76(2):147-56. PubMed ID: 10637063
    [No Abstract]   [Full Text] [Related]  

  • 29. [Estrogens and progestins in hormone replacement therapy in menopause].
    La Vecchia C
    Recenti Prog Med; 2001 Mar; 92(3):209-12. PubMed ID: 11320854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioidentical hormones.
    Well E
    Adv Nurse Pract; 2009 Sep; 17(9):37-8, 40-1. PubMed ID: 20000171
    [No Abstract]   [Full Text] [Related]  

  • 31. Oestrogens, progestins and breast proliferation.
    Thijssen JH
    Zentralbl Gynakol; 1997; 119 Suppl 2():43-7. PubMed ID: 9361394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral contraceptive use during the perimenopausal years.
    Van Winter JT; Bernard ME
    Am Fam Physician; 1998 Oct; 58(6):1373-7, 1381-2. PubMed ID: 9803201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oestrogen therapy and cardiovascular disease: do the benefits outweigh the risks?
    Bush TL; Miller-Bass K
    Baillieres Clin Obstet Gynaecol; 1991 Dec; 5(4):889-913. PubMed ID: 1822825
    [No Abstract]   [Full Text] [Related]  

  • 34. [Endocrine system. a. Hormone replacement therapy--improvement of in bone metabolism and cancer risk of long term therapy].
    Ota H
    Nihon Sanka Fujinka Gakkai Zasshi; 1994 Aug; 46(8):749-63. PubMed ID: 8089612
    [No Abstract]   [Full Text] [Related]  

  • 35. Perimenopausal use of reproductive hormones effects on breast and endometrial cancer.
    Collins JA; Schlesselman JJ
    Obstet Gynecol Clin North Am; 2002 Sep; 29(3):511-25. PubMed ID: 12353671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progestin and estrogen potency of combination oral contraceptives and endometrial cancer risk.
    Maxwell GL; Schildkraut JM; Calingaert B; Risinger JI; Dainty L; Marchbanks PA; Berchuck A; Barrett JC; Rodriguez GC
    Gynecol Oncol; 2006 Nov; 103(2):535-40. PubMed ID: 16740300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [What's new in hormone replacement therapy of postmenopausal women? II. Risks of hormone replacement therapy (HRT)].
    Martin-Du Pan RC; Luzuy F
    Rev Med Suisse Romande; 2000 Jun; 120(6):523-7. PubMed ID: 11014097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The biological role of smoking, oral contraceptive use and endogenous sexual steroid hormones in invasive squamous epithelial cervical cancer.
    Hellberg D; Stendahl U
    Anticancer Res; 2005; 25(4):3041-6. PubMed ID: 16080563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endometrial adenocarcinoma arising during estrogenic treatment 17 years after total abdominal hysterectomy and bilateral salpingo-oophorectomy: a case report.
    Debus G; Schuhmacher I
    Acta Obstet Gynecol Scand; 2001 Jun; 80(6):589-90. PubMed ID: 11380300
    [No Abstract]   [Full Text] [Related]  

  • 40. The association of endogenous sex steroids and sex steroid binding proteins with mammographic density: results from the Postmenopausal Estrogen/Progestin Interventions Mammographic Density Study.
    Greendale GA; Palla SL; Ursin G; Laughlin GA; Crandall C; Pike MC; Reboussin BA
    Am J Epidemiol; 2005 Nov; 162(9):826-34. PubMed ID: 16177147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.